Skip to content

Clinical trials

Observational Neoplasm Metastasis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Observational Country / region: Germany Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20081
20101
20121
20142
20162
20173
20192
20202
20212
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status5
Recruiting3
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
iOMEDICO AG4
Bristol-Myers Squibb2
AO Innovation Translation Center1
AbbVie (prior sponsor, Abbott)1
AstraZeneca1
Cardiovascular and Interventional Radiological Society of Europe1
Centre Leon Berard1
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1
Ludwig-Maximilians - University of Munich1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis23
Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Carcinoma, Hepatocellular2
Pancreatic Neoplasms2
Adenoma, Islet Cell1
Breast Neoplasms1
Colonic Neoplasms1
Colorectal Neoplasms1
Esophageal Neoplasms1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.